Halo's development capabilities can help bring products to market quickly. Specializing in all aspects of the CMC dosage form section of the NDA, Halo's dedicated laboratories and pilot facilities can assist at all stages of development from pre-clinical to phase III. After registration, products can progress naturally into the Whippany Commercial facilities where the same development scientists and manufacturing specialists can scale the product up for commercial supply.

We can provide the scientific, regulatory and product development expertise you need in order to bring your products quickly and effectively to market.

Dosage forms that can be supported include:

• Compressed tablets
• Coated tablets
  
• Capsules
  
• Powders
  
• Liquids
  

With equipment and systems in place that include:

• Laboratory scale blenders
• Various V blenders to accommodate a range of batch sizes and bulk density materials
• Pilot scale vertical high shear granulator
• GPCG 5 fluid bed drier
• Fitzmills and Comils
• 24" Accela Cota film coater
• Zanasi automatic encapsulation machine
  

to support the following technologies:

• Dry blending
• Direct compression tablets
• High shear granulation
• Fluid bed drying
• Tablet film coating
• Tablet compression
• Wurster column based beads and bead coating
• Encapsulation
• Controlled substances handling (DEA CII-CV)